Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tykundegex]

Good question. That's one I asked myself when a fellow member of this forum recommended I take a look. I then read all relevant SEC filings since IPO, and read all PRs, looked at all corporate presentations, and a few videos by members of the Kitov management team.

And the only likely answer I came up with was: the market is unaware or impatient. If there is risk, I cannot see it (at least, not very much). If YOU see some risks, please point them out to help your fellow iHub members. I guess selling volume on this stock does not, for me, constitute risk. Not for a clinical stage biotech with a low float, anyway

Why is the market cap at 21 million for an approved phase III multi billion $ drug potentially?